UCB Stock price

Equities

UCB

BE0003739530

Pharmaceuticals

Market Closed - Euronext Bruxelles 12:35:05 2024-03-28 pm EDT 5-day change 1st Jan Change
114.4 EUR +0.57% Intraday chart for UCB +6.27% +44.99%
Sales 2024 * 5.61B 6.05B Sales 2025 * 6.36B 6.85B Capitalization 21.58B 23.27B
Net income 2024 * 470M 507M Net income 2025 * 918M 990M EV / Sales 2024 * 4.14 x
Net Debt 2024 * 1.63B 1.76B Net Debt 2025 * 801M 863M EV / Sales 2025 * 3.52 x
P/E ratio 2024 *
53.3 x
P/E ratio 2025 *
25.4 x
Employees 8,767
Yield 2024 *
1.23%
Yield 2025 *
1.28%
Free-Float 61.42%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.09%
1 week+1.88%
Current month+6.90%
1 month+8.43%
3 months+44.92%
6 months+46.15%
Current year+44.30%
More quotes
1 week
111.05
Extreme 111.05
115.65
1 month
102.65
Extreme 102.65
115.65
Current year
78.72
Extreme 78.72
115.65
1 year
65.40
Extreme 65.4
115.65
3 years
65.40
Extreme 65.4
116.05
5 years
60.18
Extreme 60.18
116.05
10 years
54.53
Extreme 54.53
116.05
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 11-05-31
Director of Finance/CFO 57 20-06-30
Chief Tech/Sci/R&D Officer 63 17-09-30
Members of the board TitleAgeSince
Director/Board Member 66 16-04-27
Director/Board Member 73 13-12-31
Director/Board Member 69 10-04-28
More insiders
Date Price Change Volume
24-03-28 114.4 +0.57% 257 855
24-03-27 113.8 -0.66% 299,524
24-03-26 114.5 -0.78% 361,607
24-03-25 115.4 +1.01% 455,533
24-03-22 114.2 +2.24% 583,140

Real-time Euronext Bruxelles, March 28, 2024 at 06:00 am EDT

More quotes
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
113.8 EUR
Average target price
117.8 EUR
Spread / Average Target
+3.57%
Consensus
  1. Stock
  2. Equities
  3. Stock UCB - Euronext Bruxelles